Stem cell transplantation involves conditioning with TBI and/or intensive chemotherapy, which may cause longterm neuropsychological deficits, particularly in children treated at a very young age. The aim of this study was to investigate whether very young children who receive chemotherapy-based conditioning only (BUCY) may have a more favorable neuropsychological outcome than children conditioned with TBI-CY. Twenty-two children who underwent allogeneic SCT at 0.4-3.6 years of age were subject to an extensive neuropsychological assessment at an average of 6.5 years post-therapy. The test results of 10 children exposed to BU were compared to the results of 12 children who had received TBI. Ten of them had received single-dose TBI, whereas two had received fractionated TBI. The BU group performed at age level on verbal measures, but tended to score below age level in the executive and visuo-spatial domains (Po0.01). By comparison, children treated with TBI had more pervasive neuropsychological impairments, including motor deficits (Po0.01) and varying degrees of perceptual (Po0.05), executive and cognitive (Po0.05) problems. In conclusion, children transplanted at a very young age had a more favorable neuropsychological development if conditioned with BUCY than if conditioned with single-dose TBI-CY.
Introduction
Hematopoietic SCT provides curative treatment for a number of life-threatening diseases in children. The procedure was clinically introduced in the 1970s as a treatment for aggressive forms of leukemia and severe immune deficiencies, and was eventually applied successfully also in aplastic anemia and congenital metabolic disorders, including hemoglobinopathies. However, leukemia remains the major diagnostic group, constituting two-thirds of all pediatric SCT patients. The long-term survival rates are around 60% overall, but vary depending on the disorder treated, the level of HLA-matching, and other donor and patient characteristics. 1 Several treatment regimen-related late effects may arise after SCT, neuropsychological deficits being one. This paper focuses on the long-term neuropsychological outcome in 22 children treated at 0.4-3.6 years of age.
Conditioning before transplantation involves high-dose chemotherapy, for example, CY and TBI (usually 9-12 Gy), which can be substituted by another cytostatic drug, BU. From studies of animal models as well as human cancer research, it is well known that chemotherapy and irradiation constitute potentially neurotoxic treatment modalities, particularly if combined in intensified protocols. 2 As the immature brain is particularly vulnerable to generalized and diffuse insult, pretransplant conditioning may pose a risk for CNS functioning and long-term development of the child.
Around 1970, CNS preventive therapy was introduced, combining intrathecally administered chemotherapy (MTX) with cranial irradiation (18) (19) (20) (21) (22) (23) (24) , as a means to prevent relapse in children treated for ALL. Long-term survival rates were greatly improved, but at a cost. Followup studies soon revealed a host of neurological and neuropsychological disturbances in children treated with CNS prophylaxis, particularly in children treated at a very young age. Meta-analyses 3 have demonstrated that cranial irradiation is associated with greater neuro-developmental risk, such as global cognitive impairment as well as specific neuropsychological deficits in executive functions, visuospatial thinking, memory and learning. Functions intrinsic to the nondominant hemisphere appear to be most affected. [4] [5] [6] It has been suggested that diffuse white matter pathology, caused by the neurotoxic treatment agents, may be the primary mechanism underlying the observed functional deficits. [7] [8] [9] CNS preventive therapy remains an important measure in the treatment of childhood ALL, but cranial irradiation is avoided today and is used only with patients with poor prognosis and under conditions of a CNS relapse. 2, 6 Intrathecal chemotherapy alone is less harmful, but it is still associated with mild-to-moderate neuropsychological deficits in at least 30% of the patients.
Compared to the vast literature on the effects of CNS prophylaxis, there are relatively few published studies of the long-term neuropsychological development of children treated with SCT. Pretransplant protocols involve lower doses of irradiation and chemotherapy than is the case for CNS preventive therapy, but may nevertheless pose risks. As the numbers of pediatric survivors increase, it becomes possible to evaluate the psychological impact and late effects of the treatment. 12 Our own longitudinal study of children treated at Karolinska University Hospital Huddinge during the 1980s presented an early account of the risks associated with pretransplant conditioning involving a 2-day CY regimen and subsequent TBI of 10 Gy in a single dose. 13, 14 The results indicated that TBI in one dose was associated with sensory-motor and cognitive deficits and other neurological sequelae. These typically became more pronounced over time (45 year post-therapy), and were inversely related to age at treatment. Specifically, children treated with SCT, including TBI in a single dose, at 1-3.5 years of age showed a general developmental impairment, with pronounced motor deficits and varying degrees of perceptual and cognitive problems. 14 Other available studies have pointed in the same direction, [15] [16] [17] but shorter follow-up intervals, that is, outcome 1-3 years after treatment, tend to give a more favorable account of the children's development. [18] [19] [20] [21] [22] Some studies report data from quite small samples 23 and few have included specific neuropsychological measures. As is often the case in pediatric clinical research, the cohorts are quite heterogeneous and may not have enough statistical power to disclose the possible effects of therapeutic modality, post-therapeutic interval, treatment age and gender, as well as the interactions between these factors. Nevertheless, there is relative agreement that patients receiving TBI-CY at infant or preschool age run a greater risk for impaired development than older children. However, developmental data from very young children treated with BUCY are scarce and inconclusive. 22, 24, 25 According to several studies, pretransplant conditioning with TBI is associated with somewhat better chances for long-term survival in acute leukemia compared to a BU regimen, particularly in ALL. 26, 27 Yet, on the basis of known developmental risks, irradiation is generally avoided in the treatment of very young children. To confirm the rationale behind this, we need better knowledge of the developmental outcome in very young children conditioned with BUCY.
Hence, the aim of this study was to investigate possible differences in neuropsychological outcome in children treated with SCT before 4 years of age, in relation to pretransplant conditioning with BUCY compared to fractionated and single-dosed TBI-CY.
Patients and methods
Patients who had received SCT at Karolinska University Hospital Huddinge between 1992 and 2004, with either a TBI-CY or BUCY conditioning protocol, who had been under 4 years at the time of transplant, and who were in stable medical condition and at least 1 year post treatment, were asked to participate. During 2004-2005, a total of 17 former SCT patients who fulfilled the criteria were invited to participate in the study. Five families declined participation; two because the child was unwilling to spend more time on check-ups, one because the child had an ongoing contact with a child psychologist/psychiatrist elsewhere, one due to acute family stress and one due to language problems. The drop outs did not differ systematically from the 12 children who chose to participate in terms of diagnoses, treatment protocol or age at SCT. Participants in the study were subjected to a neuropsychological examination in [2004] [2005] . The mean post-therapeutic interval was 6.5 years (s.d. 3.5 years; median 6.0 years), and the intent was to make further follow-ups within 2-3 years. Neuropsychological data from an additional two patients, who fulfilled the criteria but had been assessed already in 1997-1999, were also included, making the total number of patients n ¼ 14.
Ten of the 14 children had received BU, at a total p.o. dose of 16 mg/kg over 4 days, which was adjusted according to pharmacological monitoring to a target area under the curve, and i.v. CY 120 mg/kg over 2 days in patients with leukemia (n ¼ 3) or myelodysplastic syndrome (n ¼ 1), or 200 mg/kg over 4 days in nonmalignant cases (n ¼ 6). Two children had received fractionated TBI (8 Â 1.8 and 4 Â 3 Gy, respectively) plus CY 120 mg/kg, and two had received TBI 10 Gy in a single dose (with shielding of the lungs to receive 9 Gy) with CY 120 mg/kg. An overview of the patients, by treatment protocol, diagnosis, age at SCT and age at assessment, is given in Table 1 . In addition, and for reasons of comparison, neuropsychological data from eight patients transplanted between 1980 and 1992 were included in the analyses. These patients had been treated for malignant disease at 1.0-3.3 years of age, and all of them had received 10 Gy single-dose TBI and 120 mg/kg CY as conditioning; two of them had also received fractionated cranial irradiation of 18-19 Gy as CNS prophylaxis earlier (see Table 1 and an earlier publication, 14).
Procedure
The study was approved by the Stockholm Regional Ethics Board (March 2004). Before the annual check-up at the Karolinska University Hospital Huddinge, parents had been informed about the study and had given their consent. Most children were tested at the hospital, but a few preferred to have the assessment performed in their own home. All children were tested by the first author (A-CS), who is an experienced child neuropsychologist and who had previously tested the eight children transplanted in 1980-1992. The effective testing time was 4-5 h per child, allocated over 1 or 2 days, according to the needs of the individual child and family. The neuropsychological examination followed essentially the same protocol as our previous follow-up study, 13, 14 covering the functional domains and tests presented in Table 2 . [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] Tests of sensory-motor and specific cognitive functions, such as executive functions and memory, were included to the extent that the developmental level of the individual child permitted; in general, a complete neuropsychological examination could be performed in children who were 6.5 years or older at the time of assessment. As a measure of general cognitive level, children older than 6.5 years (n ¼ 10) were administered the Swedish WISC-III, 39, 40 whereas the Swedish WPPSI-R 39,41 was given to children assessed at 4.0-6.5 years of age (n ¼ 4); see Table 1 . With two of the very youngest children, complementary observations were made with the Swedish Griffiths Scale II, [42] [43] [44] which provides norms on a stanine scale. An account of each child's development and overall family adjustment post treatment was obtained through a parental interview.
Data analysis
As a first step, individual raw test scores were transformed into scaled scores (IQ or z-scores) by comparison with ageappropriate normative data. 28, 29, [31] [32] [33] [35] [36] [37] 40, 41 Individual test results were analyzed by functional domain, and results falling one standard deviation below the age norm were made note of. Individual assessments were summarized and compared to qualitative data from the parental interview. For statistical analyses, test data were handled by SPSS. One group t-tests were performed to test whether the present patient group (n ¼ 14) deviated significantly from the norm on intelligence tests and other measures that were approximately normally distributed. Statistical tests were applied to illuminate the magnitude of differences in performance, but not for strict hypothesis testing. Hence, the level of significance was set at 0.05 (two-tailed), without Bonferroni correction. In the subsequent analyses, patients treated in 1980-1992 (n ¼ 8) were included. Test results of children who had received a TBI regimen (n ¼ 12, including the eight historic patients) were compared to results of children who had received BU (n ¼ 10), descriptively and, whenever possible, by parametric (independent groups t-tests) or nonparametric (Mann-Whitney U) statistical tests. In addition, all children (n ¼ 22) were assigned to one of four groups according to pretransplant conditioning and, where applicable, prophylactic cranial irradiation as part of conventional ALL therapy: (1) BU (n ¼ 10), (2) fractionated TBI (n ¼ 2), (3) single-dose TBI (n ¼ 8, of which six were historic patients) and (4) single-dose TBI þ prior cranial irradiation (n ¼ 2 historic patients). On the basis of the assumption that conditioning of types 1-4 inflict a gradual increase in potential neurotoxicity, the effect of conditioning on cognitive outcome was explored in a series of multiple regression analyses. As would be expected, the test score distributions of most of the specific neuropsychological measures were negatively skewed; in combination with the great variation of age at assessment and age-related partial attrition, this precluded any more sophisticated statistical analyses. 
Test results in relation to pretransplant conditioning (n ¼ 22)
To explore the impact of conditioning, the historic patients were included in the analyses that follow. Irradiated (n ¼ 12, including eight patients conditioned with singledose TBI-CY in 1980-1992) and nonirradiated, that is, BUCY-conditioned, children (n ¼ 10) were compared. The BUCY group performed better on all measures, although the differences were statistically significant (t-tests, 0.05, two-tailed) only for Verbal IQ, Full Scale IQ, Visual Motor Integration, Finger Tapping, and the gross motor measures of Balance and Bilateral coordination; see Table 3 . Case analysis revealed that the majority of the TBI-exposed children, including the two patients who had received fractionated TBI, displayed clinically significant deficits. Memory for story 31, 32 Rey Complex Figure Test-recall   38 This was not the case for the group of children exposed to BU; see Table 4 . For a further exploration of the impact of conditioning, a series of multiple regression analyses were conducted, with age at SCT and conditioning (1-4, as described in the Patients and methods section) as the independent variables and neuropsychological test result as the dependent variable. The enter method was used, with a correlation at the Po0.05 level needed for a predictor to enter. Length of follow-up had zero correlation to outcome measures and was not included. Significant models emerged for Verbal IQ, Finger Tapping and Bilateral Coordination, accounting for 19, 21 and 48% of the test variance, respectively. Conditioning was the significant predictor (o0.05) variable in the models, whereas age at SCT did not predict outcome within this group of children treated at age 0-3.6 years. Figure 1 presents an illustration of the relationship between conditioning regimen and intelligence.
Discussion
The primary research question was: Do very young SCT recipients have a more favorable neuropsychological outcome when conditioned with BUCY than with TBI-CY?
Based strictly on our findings, the answer would be yes. Given the diagnostic heterogeneity in the group studied, the effect of conditioning was surprisingly clear-cut. The group of 10 children conditioned with BUCY performed completely at age level in the verbal domain. Mild-to-moderate deficits relative to age norm were observed in visuo-spatial cognitive functioning, attention, mental speed and working memory. However, these deficits were mostly of a subclinical nature and were not seen in all children. By comparison, children treated with TBI-CY, 10 out of 12 in a single dose, displayed more pervasive and severe neuropsychological deficits that tended to have a negative impact on the child's daily life, adaptation and educational attainment. The positive developmental outcome for the BUCY group was further accentuated by the fact that these Neuropsychological outcome in young SCT patients A-C Smedler and J Winiarski children had indeed been very young at treatment. Four of them, including two with malignant disease, were treated well before their first birthday. The mean age at SCT was 1.8 years, which was slightly younger than the TBI group (2.3 years; NS). To summarize, children in this study, who had been exposed to BUCY, had a markedly better longterm development than children exposed to single-dose TBI-CY. However, before drawing conclusions, the limitations of this study must be considered. First and foremost, the group studied is heterogeneous both in terms of diagnoses and previous treatments, factors that may influence developmental outcome. [2] [3] [4] [5] [6] Table 1 displays this heterogeneity within and between conditioning groups. More children in the TBI-CY group, as compared to the BUCY group, had suffered from malignancies and had experienced previous aggressive treatments. We do not have any pretreatment assessments, but according to the parental interviews, no child had displayed any developmental delay before SCT. This does not preclude that disease-related and medical events before SCT may have had a negative longterm impact on individual children. However, according to case analyses, treatment before conditioning did not appear to have a systematic negative impact on outcome in this group of very young patients, with the obvious exception of cranial irradiation. The four children who were treated for leukemia in second remission, without prior cranial irradiation, (two AML CR2/BUCY; two ALL CR2/TBI-CY), developed equally well as other children exposed to the same type of conditioning. Most of the nonmalignant patients had received BUCY and had not had any other treatment before conditioning; still, their average test performance was in no way superior to that of patients treated for malignancies receiving the same type of conditioning. It should be mentioned that none of the children who had suffered from hemoglobinopathies, all of them conditioned with BUCY, had experienced any CNS events.
A second point of concern is the variation in protocols within the TBI-CY group. It must be stressed that 10 out of 12 irradiated children had received single-dose TBI, a treatment regimen that is rarely used today. Eight of them had been treated already in 1980-1992, and were included to allow for comparisons with children who had received more contemporary conditioning regimens. A drawback with the inclusion of 'historic patients' is that additional cohort effects, unrelated to conditioning, may influence the results of the TBI-CY group. One aim of this study was to explore the developmental impact of fractionated TBI, which is the contemporary standard, as compared to singledose TBI. As conditioning using TBI has in recent years been mainly restricted to children with ALL, only two of the participating children had received fractionated TBI and such a comparison was not possible. It was, however, noted that these two displayed clinically significant deficits. In addition, the multiple regression analyses indicated that the negative impact of irradiation may indeed be dosedependent, as was also illustrated in Figure 1 , and would be consistent with previous research. 2, 45 A third point of concern is the variability in age at assessment, and hence in follow-up time. Variation in assessment age was handled by choosing age-appropriate test versions and evaluating individual results in relation to normative data, and statistical analyses were based on scaled scores. Analyses of individual results were carried out conservatively, with attention being paid only to results falling at least one standard deviation below the age norm (see Table 4 ). As to the length of follow-up, previous research has demonstrated that treatment-related impairments may not become manifest until several years later. 6, [13] [14] [15] [16] [17] Studies with follow-up intervals of only 1-3 years will typically give a more positive view of the children's development. [18] [19] [20] [21] [22] It is a strength of this study that the average follow-up time was as long as 6.5 years (Md 6.0 years). The length of follow-up was equally distributed in the BUCY and TBI-CY groups (see Table 3 ), and according to our regression analyses unrelated to developmental outcome. This may mean that, at large, the follow-up times were long enough for potential developmental problems to occur and stabilize. It may also mean that the effect of pretransplant conditioning overshadowed other possible sources of systematic variance.
In conclusion, the results of our study strongly indicate that for very young transplant recipients, conditioning with BUCY is associated with a significantly better neuropsychological outcome than that with single-dose TBI-CY. Nevertheless, our findings need to be replicated, and there is a general need for more systematic research in this area. In particular, there is a need for follow-up studies of very young patients who have been administered fractionated instead of single-dose TBI. In respect to contemporary regimens, our study may give an unduly negative account of the long-term effect of TBI. It should also be stressed that the favorable outcome in very young children treated with BUCY, as compared to a single-dose TBI-CY regimen, cannot be extrapolated to older pediatric patients. Comparative studies covering other ages as well are very much needed.
According to the literature, functional deficits associated with chemotherapy are not identical to deficits typically seen after irradiation 3, 6 and may indeed be related to different underlying mechanisms. Irradiation of the CNS has been most strongly linked to white matter pathology, indirectly in studies of neuropsychological functioning, [4] [5] [6] 8 and directly in magnetic resonance studies. 9 The CNS effects of chemotherapy are complex and far from understood; cortical as well as white matter lesions may be involved, 46 leading to functional disturbances of a transient or enduring nature. 3 Functional outcome depends both on the magnitude of the CNS lesion and on individual differences in plasticity. According to Stern 47,  individual differences in functional outcome may be explained by the theoretical construct of reserve capacity, encompassing both the passive capacity of the brain (brain reserve capacity; BRC) and the active capacity of the individual (cognitive reserve capacity; CRC). Recently, Dennis 48 demonstrated that these concepts may be used for predicting developmental outcome in children who have suffered CNS insult. With reference to the developmental model proposed by Dennis, our findings indicate that the brain reserve of the child may be taxed by the treatment, particularly by irradiation, and more so if treatment is intensified. The child's cognitive reserve is determined by his or her developmental level at the time of illness and treatment. Family factors are also seen as part of the cognitive reserve. Outcome is mediated by brain and cognitive reserves, and moderated by age at treatment as well as age at assessment. Hence, the developmental model proposed by Dennis fits nicely with our data and may explain why children treated at a very young age with intensified protocols run a greater risk for developmental impairment.
